Drug Intervention Institute partners with Harm Reduction Therapeutics to provide low-cost life-saving RiVive™ 3 mg naloxone nasal spray inside ONEbox™

by C Tetro | Mar 1, 2024 | News

Higher naloxone doses have no impact on overdose survival, study shows

by C Tetro | Feb 8, 2024 | News

Bystander Naloxone Administration: Amounts and Dosages versus EMS Naloxone Administration

by C Tetro | Feb 3, 2024 | News

Open Society Supports an Innovative Model to Make Naloxone Easier to Access Amidst the U.S. Overdose Crisis

by C Tetro | Dec 12, 2023 | News

Partnership to Save Lives: Harm Reduction Therapeutics to donate 200,000 RiVive™ naloxone doses to Remedy Alliance for free distribution

by C Tetro | Aug 17, 2023 | News